Five Reasons Medical Cannabis is Booming
- Jun 19
- 3 min read
Amanda Müessli is an international entrepreneur and founder specializing in agriculture and medical cannabis. As the founder and CEO of Green Tech Global, she advises governments, investors, and private enterprises on cultivation, processing, compliance, and market development projects across Europe, the Middle East, Africa, Asia, and North America.
Medical cannabis is no longer a niche industry. What was once a highly stigmatized plant is now becoming one of the fastest-growing sectors in healthcare, agriculture, and international trade. Having spent over a decade working in cultivation, facility development, compliance, and international medical cannabis projects across multiple continents, I have witnessed firsthand how rapidly this industry is evolving. The conversation has shifted. Governments are no longer asking if medical cannabis should exist. They are asking how they can build sustainable industries around it.
Here are five reasons why medical cannabis is booming worldwide
Science is replacing stigma: For years, cannabis was viewed through a political lens rather than a medical one. Today, that is changing. Researchers, physicians, and regulators are increasingly looking at clinical data and patient outcomes. As scientific understanding grows, so does confidence in medical cannabis as a legitimate treatment option for a range of conditions. The industry is moving away from opinions and toward evidence-based medicine.
Governments see economic opportunity: Medical cannabis is not just a healthcare conversation anymore. It is an economic development strategy. Countries around the world are creating regulatory frameworks that attract investment, generate exports, create jobs, and support agricultural innovation. For emerging economies in particular, medical cannabis represents an opportunity to participate in a high-value global industry while creating employment and increasing foreign revenue.
Global demand continues to rise: Patient demand continues to grow year after year. As more countries introduce medical cannabis programs, the need for pharmaceutical-grade products increases. This has created significant opportunities for cultivators, manufacturers, laboratories, and exporters. The reality is simple: demand is growing faster than many markets can currently supply. This is creating opportunities for businesses that prioritize quality, compliance, and consistency.
The industry is becoming more professional: The days of informal cannabis operations are disappearing. Today’s successful medical cannabis companies operate like pharmaceutical businesses. They invest in quality management systems, EU GMP standards, research and development, data collection, and regulatory compliance. The companies that thrive in the next decade will not necessarily be the biggest. They will be the most compliant, efficient, and reliable. Professionalization is transforming the industry and creating greater trust among regulators, healthcare providers, and patients.
Innovation is accelerating: Medical cannabis sits at the intersection of healthcare, biotechnology, agriculture, and manufacturing. From advanced genetics and tissue culture to AI-driven cultivation systems and pharmaceutical-grade extraction technologies, innovation is happening at an incredible pace. The companies investing in research today will shape the future of medicine tomorrow. We are only beginning to understand the full potential of cannabinoids, and that is what makes this industry so exciting.
Final thoughts
Medical cannabis is no longer an emerging market. It is becoming a global industry. The countries, companies, and investors who recognize this shift early will be best positioned to benefit from the opportunities ahead.
Having worked on medical cannabis projects across Europe, the Middle East, Asia, Africa, and North America, one thing has become clear to me: This industry is not slowing down. It is only getting started.
Read more from Amanda Muessli
Amanda Muessli, Founder and CEO of Green Tech Global
Amanda Müessli is an international entrepreneur and business strategist with over a decade of experience in agriculture and medical cannabis. As founder and CEO of Green Tech Global, she works with governments, investors, and private enterprises to develop cultivation, processing, and export-focused projects worldwide. Her expertise spans cultivation infrastructure, regulatory compliance, operational strategy, and international market development. Amanda is passionate about advancing sustainable agriculture, innovation, and emerging industries across global markets.
